Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19
Shayan Riahi, Lorenna Rodrigues Silva Sombra, Kevin Bryan Lo, Shireen R Chacko, Alvaro Goncalves Mendes Neto, Zurab Azmaiparashvili, Gabriel Patarroyo‐Aponte, Janani Rangaswami, Catherine Anastasopoulou
Abstract
: Among diabetic patients infected with COVID-19, insulin therapy at home was significantly independently associated with increased mortality. Peak daily inpatient insulin requirements was also independently associated with increased inpatient mortality.
Topics & Concepts
Diabetes mellitusMedicineCoronavirus disease 2019 (COVID-19)InsulinCoronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Diabetes controlInternal medicineCoronavirus InfectionsBetacoronavirusIntensive care medicineType 2 diabetesVirologyEndocrinologyDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and Research